Pemphigoid Gestationis Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Pemphigoid Gestationis
Pemphigoid Gestationis (PG), formerly known as herpes gestationis, is a rare autoimmune blistering disease that affects approximately 1 in 50,000 to 60,000 pregnancies. Typically emerging in the second or third trimester, or sometimes immediately after delivery, PG is characterized by an intensely itchy rash. It often begins as red, raised bumps or patches, frequently appearing around the navel, before spreading to the trunk and limbs. These lesions can then evolve into fluid-filled blisters, causing significant discomfort and distress for expectant mothers. While the rash usually resolves within weeks or months after delivery, it can recur in subsequent pregnancies and with oral contraceptive use. Most cases result in healthy outcomes for both mother and baby, though there's a slightly increased risk of preterm birth or babies being small for gestational age.
Managing Pemphigoid Gestationis primarily focuses on alleviating the severe itching and preventing the formation of new lesions. Treatment is always tailored by a healthcare provider. For milder cases, topical corticosteroids, such as clobetasol or triamcinolone creams, are often prescribed to soothe the skin and reduce inflammation.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.